Rational Design of a Glycoconjugate Vaccine against Group A


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
13 Nov 2020
Historique:
received: 30 09 2020
revised: 05 11 2020
accepted: 10 11 2020
entrez: 18 11 2020
pubmed: 19 11 2020
medline: 4 3 2021
Statut: epublish

Résumé

No commercial vaccine is yet available against Group A

Identifiants

pubmed: 33202815
pii: ijms21228558
doi: 10.3390/ijms21228558
pmc: PMC7696035
pii:
doi:

Substances chimiques

Antigens, Bacterial 0
Bacterial Proteins 0
Glycoconjugates 0
Streptococcal Vaccines 0
Vaccines, Conjugate 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Infect Immun. 2011 Oct;79(10):4240-9
pubmed: 21807909
Curr Top Microbiol Immunol. 2013;368:1-27
pubmed: 23242849
PLoS One. 2018 Jul 2;13(7):e0198658
pubmed: 29965967
ACS Chem Biol. 2015 Jul 17;10(7):1737-46
pubmed: 25906283
Biochem J. 2018 Sep 11;475(17):2847-2860
pubmed: 30049896
Nat Med. 2018 Jan 9;24(1):10-19
pubmed: 29315295
J Pharm Sci. 2016 Oct;105(10):3046-3056
pubmed: 27522919
FEMS Immunol Med Microbiol. 2004 Apr 9;40(3):193-9
pubmed: 15039094
Vaccine. 2010 Aug 2;28(34):5513-23
pubmed: 20600514
Bioorg Chem. 2020 Jun;99:103815
pubmed: 32289587
Vaccine. 2011 Oct 26;29(46):8175-8
pubmed: 21920403
Glycobiology. 2011 Apr;21(4):401-9
pubmed: 21030538
Mol Cell Proteomics. 2012 Jun;11(6):M111.015693
pubmed: 22286755
J Biol Chem. 2017 Nov 24;292(47):19441-19457
pubmed: 29021255
J Infect Dis. 1995 Mar;171(3):593-600
pubmed: 7876606
N Engl J Med. 2017 Aug 24;377(8):713-722
pubmed: 28834488
Vaccine. 1998 Nov;16(18):1732-41
pubmed: 9778749
Vaccine. 2014 Oct 21;32(46):6122-9
pubmed: 25192974
Science. 2002 Nov 29;298(5599):1790-3
pubmed: 12459590
Clin Infect Dis. 2019 Aug 16;69(5):877-883
pubmed: 30624673
Expert Opin Drug Discov. 2011 Oct;6(10):1045-66
pubmed: 22646863
Nat Genet. 2019 Jun;51(6):1035-1043
pubmed: 31133745
Vaccine. 2018 May 24;36(22):3169-3179
pubmed: 28506515
Int J Pharm. 2016 Sep 25;511(2):1098-111
pubmed: 27523619
Comput Struct Biotechnol J. 2020 Mar 13;18:650-660
pubmed: 32257048
Angew Chem Int Ed Engl. 2015 Nov 2;54(45):13198-203
pubmed: 26350581
Front Immunol. 2015 Nov 16;6:581
pubmed: 26635795
J Infect Dis. 2005 Sep 1;192(5):783-90
pubmed: 16088827
J Bacteriol. 1988 Jun;170(6):2618-24
pubmed: 2453502
PLoS One. 2012;7(10):e46648
pubmed: 23077517
J Clin Microbiol. 1978 Dec;8(6):725-8
pubmed: 370147
J Immunol Methods. 2019 Aug;471:11-17
pubmed: 31039338
J Immunol Methods. 2008 Aug 20;337(1):35-41
pubmed: 18572188
mBio. 2013 Jan 08;4(1):e00387-12
pubmed: 23300245
mSphere. 2019 Sep 25;4(5):
pubmed: 31554723
PLoS One. 2013 Nov 14;8(11):e79304
pubmed: 24244473
Clin Microbiol Rev. 2014 Apr;27(2):264-301
pubmed: 24696436
Lancet Infect Dis. 2009 Oct;9(10):611-6
pubmed: 19778763
Infect Immun. 2014 Jul;82(7):2890-901
pubmed: 24778116
Vaccine. 1995 Oct;13(14):1288-93
pubmed: 8585282
J Infect Dis. 2014 May 15;209(10):1551-61
pubmed: 24308931
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013 Oct;69(Pt 10):1103-6
pubmed: 24100558
Curr Opin Immunol. 2020 Apr 30;65:42-49
pubmed: 32361591
J Chromatogr A. 2014 Jun 27;1348:137-49
pubmed: 24845825
Bioconjug Chem. 2015 Aug 19;26(8):1839-49
pubmed: 26230938
J Pharm Biomed Anal. 2000 Jan;21(6):1087-91
pubmed: 10708393
Sci Transl Med. 2018 Aug 29;10(456):
pubmed: 30158151
Molecules. 2018 Jun 15;23(6):
pubmed: 29914046
ACS Infect Dis. 2020 Feb 14;6(2):281-290
pubmed: 31872763
Clin Microbiol Rev. 2000 Jul;13(3):470-511
pubmed: 10885988
J Infect Dis. 2006 Jan 1;193(1):129-35
pubmed: 16323141
mBio. 2016 Jun 14;7(3):
pubmed: 27302756
Vaccine. 2010 Dec 10;29(1):104-14
pubmed: 20870056
JAMA Pediatr. 2014 Nov;168(11):1073-4
pubmed: 25264869
PLoS One. 2015 Oct 07;10(10):e0139847
pubmed: 26445460
Can J Biochem Cell Biol. 1984 May;62(5):270-5
pubmed: 6733568
Vaccine. 2016 Jul 29;34(35):4235-4242
pubmed: 27317455
Anal Chem. 2020 May 5;92(9):6304-6311
pubmed: 32330386
Lancet Infect Dis. 2005 Nov;5(11):685-94
pubmed: 16253886
Vaccine. 2016 Jun 3;34(26):2953-2958
pubmed: 27032515
PLoS One. 2013 Apr 08;8(4):e60969
pubmed: 23593359
J Exp Med. 1980 Aug 1;152(2):361-76
pubmed: 6967514

Auteurs

Roberta Di Benedetto (R)

GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy.

Francesca Mancini (F)

GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy.

Martina Carducci (M)

GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy.

Gianmarco Gasperini (G)

GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy.

Danilo Gomes Moriel (DG)

GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy.

Allan Saul (A)

GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy.

Francesca Necchi (F)

GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy.

Rino Rappuoli (R)

GSK, Via Fiorentina 1, 53100 Siena, Italy.

Francesca Micoli (F)

GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH